Previous close | 12,364.00 |
Open | 0.00 |
Bid | 0.00 x 0 |
Ask | 0.00 x 0 |
Day's range | 0.00 - 0.00 |
52-week range | |
Volume | |
Avg. volume | 2,630,087 |
Market cap | 191.61B |
Beta (5Y monthly) | 0.16 |
PE ratio (TTM) | 38.75 |
EPS (TTM) | 3.19 |
Earnings date | 25 Jul 2024 |
Forward dividend & yield | 2.28 (1.84%) |
Ex-dividend date | 22 Feb 2024 |
1y target est | 128.81 |
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Astrazeneca (AZN) have what it takes? Let's find out.
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
WILMINGTON, Del., May 22, 2024--AstraZeneca advances its ambition to redefine cancer care with new data across its industry-leading portfolio and pipeline at the American Society of Clinical Oncology (ASCO) Annual Meeting, May 31 to June 4, 2024.